{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:49:10Z","timestamp":1790272150659,"version":"4.1.0"},"reference-count":42,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"25","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO"],"published-print":{"date-parts":[[2021,9,1]]},"abstract":"<jats:sec>\n                    <jats:title>PURPOSE<\/jats:title>\n                    <jats:p>Frail patients with newly diagnosed multiple myeloma have an inferior outcome, mainly because of a high discontinuation rate due to toxicity. We designed a phase II trial specifically for frail patients, evaluating the efficacy and tolerability of ixazomib-daratumumab-low-dose-dexamethasone (Ixa-Dara-dex).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>Sixty-five patients, who were frail according to the International Myeloma Working Group frailty index, were treated with nine induction cycles Ixa-Dara-dex followed by maintenance with Ixa-Dara for a maximum of 2 years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>The overall response rate on induction therapy was 78%. After a median follow-up of 22.9 months, median progression-free survival (PFS) was 13.8 months and 12-month overall survival (OS) was 78%. Median PFS and 12-month OS were 21.6 months and 92% in patients who were frail based on age &gt; 80 years alone, versus 13.8 months and 78%, and 10.1 months and 70% in patients who were frail based on additional frailty parameters either \u2264 80 or &gt; 80 years of age, respectively. In 51% of patients, induction therapy had to be discontinued prematurely, of which 6% because of noncompliance to study treatment, 9% because of toxicity, and 9% because of death (8% within 2 months, of which 80% because of toxicity). Quality of life improved during induction treatment, being clinically meaningful already after three induction cycles.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>Ixa-Dara-dex lead to a high response rate and improved quality of life. However, treatment discontinuation because of toxicity and early mortality, negatively influencing PFS and OS, remains a concern in frail patients. The outcome was heterogeneous across frail subpopulations. This should be taken into account in the design and interpretation of future studies in frail patients, to pave the way for more precise treatment guidance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1200\/jco.20.03143","type":"journal-article","created":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T16:01:56Z","timestamp":1620144116000},"page":"2758-2767","update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":61,"title":["Ixazomib, Daratumumab, and Low-Dose Dexamethasone in Frail Patients With Newly Diagnosed Multiple Myeloma: The Hovon 143 Study"],"prefix":"10.1200","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7476-0609","authenticated-orcid":false,"given":"Claudia A. M.","family":"Stege","sequence":"first","affiliation":[{"name":"Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5666-5015","authenticated-orcid":false,"given":"Kazem","family":"Nasserinejad","sequence":"additional","affiliation":[{"name":"HOVON Data Center, Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"van der Spek","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Rijnstate Hospital, Arnhem, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yavuz M.","family":"Bilgin","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Admiraal de Ruijter Hospital, Goes, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1255-867X","authenticated-orcid":false,"given":"Alain","family":"Kentos","sequence":"additional","affiliation":[{"name":"Department of Hematology, Centre Hospitalier Jolimont, Haine-Saint-Paul, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maaike","family":"Sohne","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine\/Hematology, St Antonius Hospital, Nieuwegein, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roel J. W.","family":"van Kampen","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Zuyderland Medical Center, Sittard-Geleen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge","family":"Ludwig","sequence":"additional","affiliation":[{"name":"Department of Hematology, Bernhoven Hospital, Uden, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noortje","family":"Thielen","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Diakonessenhuis, Utrecht, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazik","family":"Durdu-Rayman","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine-Hematology, Franciscus Hospital location Vlietland, Schiedam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6147-0856","authenticated-orcid":false,"given":"Nicole C. H. P.","family":"de Graauw","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Bravis Hospital, Roosendaal, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels W. C. J.","family":"van de Donk","sequence":"additional","affiliation":[{"name":"Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther G. M.","family":"de Waal","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Medisch Centrum Leeuwarden, Leeuwarden, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5198-495X","authenticated-orcid":false,"given":"Marie-Christiane","family":"Vekemans","sequence":"additional","affiliation":[{"name":"Department of Hematology, St Luc Hospital, Bruxelles, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert Jan","family":"Timmers","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Amstelland Hospital, Amstelveen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3333-1327","authenticated-orcid":false,"given":"Marjolein","family":"van der Klift","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Amphia Hospital, Breda, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savita","family":"Soechit","sequence":"additional","affiliation":[{"name":"Department of Hematology, Reinier de Graaf Groep, Delft, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1737-7133","authenticated-orcid":false,"given":"Paul A. F.","family":"Geerts","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Deventer Hospital, Deventer, the Netherlands; Currently Isala, Zwolle, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthijs H.","family":"Silbermann","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Tergooi Hospital, Hilversum, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6742-9261","authenticated-orcid":false,"given":"Margriet","family":"Oosterveld","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Canisius-Wilhelmina Hospital, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inger S.","family":"Nijhof","sequence":"additional","affiliation":[{"name":"Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0808-2237","authenticated-orcid":false,"given":"Pieter","family":"Sonneveld","sequence":"additional","affiliation":[{"name":"Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia K.","family":"Klein","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Meander Medical Center, Amersfoort, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2139-3547","authenticated-orcid":false,"given":"Mark-David","family":"Levin","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5011-1820","authenticated-orcid":false,"given":"Sonja","family":"Zweegman","sequence":"additional","affiliation":[{"name":"Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"b1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1011442"},{"key":"b3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1714678"},{"key":"b4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1817249"},{"key":"b5","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2016.148189"},{"key":"b6","volume":"132","author":"Stege CAM","year":"2018","journal-title":"Blood"},{"key":"b7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-12-615187"},{"key":"b8","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2016.36"},{"key":"b9","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.226407"},{"key":"b10","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-019-0384-1"},{"key":"b11","first-page":"2873","volume":"105","author":"Zweegman S","year":"2020","journal-title":"Haematologica"},{"key":"b12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1516282"},{"key":"b13","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2017.1344212"},{"key":"b14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31594-X"},{"key":"b15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1606038"},{"key":"b16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1607751"},{"key":"b17","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32956-3"},{"key":"b18","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(09)70284-0"},{"key":"b19","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30206-6"},{"key":"b20","doi-asserted-by":"publisher","DOI":"10.1002\/sim.3123"},{"key":"b21","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v081.i08"},{"key":"b22","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/85.5.365"},{"key":"b23","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(99)00071-2"},{"key":"b24","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-114668"},{"key":"b25","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-121694"},{"key":"b26","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.36.15_suppl.8042"},{"key":"b27","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.01370"},{"key":"b28","volume":"36","author":"Celis ESPD","year":"2018","journal-title":"J Clin Oncol"},{"key":"b29","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23968"},{"key":"b30","doi-asserted-by":"publisher","DOI":"10.1002\/pon.5054"},{"key":"b31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgo.2020.06.002"},{"key":"b32","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-136292"},{"key":"b33","doi-asserted-by":"publisher","DOI":"10.3122\/jabfm.17.5.309"},{"key":"b34","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-015-3032-y"},{"key":"b35","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30506-6"},{"key":"b36","doi-asserted-by":"publisher","DOI":"10.1097\/01.HS9.0000560632.24271.d7"},{"key":"b37","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2018.07.003"},{"key":"b38","author":"D'Agostino M","year":"2020","journal-title":"EHA Libary"},{"key":"b39","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-019-0539-0"},{"key":"b40","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djy169"},{"key":"b41","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2011.056176"},{"key":"b42","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-631200"},{"key":"b43","volume-title":"Common Terminology Criteria for Adverse Events (CTCAE) version 4.0","author":"US Department of Health and Human Services, National Institutes of Health, National Cancer Institute","year":"2009"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.20.03143","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,29]],"date-time":"2022-05-29T03:05:35Z","timestamp":1653793535000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.20.03143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,1]]},"references-count":42,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2021,9,1]]}},"alternative-id":["10.1200\/JCO.20.03143"],"URL":"https:\/\/doi.org\/10.1200\/jco.20.03143","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,1]]},"assertion":[{"value":"2020-10-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-01","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}